Anamnestic recall of stroke-related deficits: An animal model

Stroke

Volumn 41, Issue 11, 2010, Pages 2653-2660

  Zierath, Dannielle ^a   Hadwin, Jessica ^a   Savos, Anna ^a   Carter, Kelly T ^a   Kunze, Allison ^a   Becker, Kyra J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

immunology; infectious disease; inflammation; lymphocytes; outcome; Th1

Indexed keywords

LIPOPOLYSACCHARIDE; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEOLIPID PROTEIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTHANASIA; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; LYMPHOCYTE COUNT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; SPLEEN CELL; STROKE;

AMNESIA; ANIMALS; BRAIN; HYPERSENSITIVITY, DELAYED; IMMUNE SYSTEM; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPOPOLYSACCHARIDES; MALE; MODELS, ANIMAL; MYELIN BASIC PROTEINS; NERVOUS SYSTEM DISEASES; RATS; RATS, INBRED LEW; STROKE; TH1 CELLS; TIME FACTORS;

EID: 78149300162     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.592865     Document Type: Article

References (29)

1. Collins FM. Cellular antimicrobial immunity. CRC Crit Rev Microbiol. 1978;7:27-91.
2. Becker KJ, Kindrick DL, Lester MP, Shea C, Ye ZC. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab. 2005;25:1634-1644.
3. Zierath D, Thullbery M, Hadwin J, Gee JM, Savos A, Kalil A, Becker KJ. CNS immune responses following experimental stroke. Neurocrit Care. 2010;12:274-284.
4. Archambault AS, Sim J, Gimenez MA, Russell JH. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur J Immunol. 2005;35:1076-1085.
5. Becher B, Bechmann I, Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med. 2006;84:532-543.
6. Richert JR, Driscoll BF, Kies MW, Alvord EC Jr. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen. J Immunol. 1979;122:494-496.
7. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476.
8. Hernandez TD, Schallert T. Seizures and recovery from experimental brain damage. Exp Neurol. 1988;102:318-324.
9. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA. Functional assessments in mice and rats after focal stroke. Neuropharmacology. 2000;39:806-816.
10. Ding Y, Zhou Y, Lai Q, Li J, Park H, Diaz FG. Impaired motor activity and motor learning function in rat with middle cerebral artery occlusion. Behav Brain Res. 2002;132:29-36.
11. Becker K, Kindrick D, McCarron R, Hallenbeck J, Winn R. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke. 2003;34:1809-1815.
12. Gee JM, Kalil A, Thullbery M, Becker KJ. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoim-munity and improves outcome after stroke. Stroke. 2008;39:1575-1582.
13. Ishigami T, White CA, Pender MP. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. Eur J Immunol. 1998;28: 1626-1635.
14. Tischner D, Weishaupt A, van den Brandt J, Muller N, Beyersdorf N, Ip CW, Toyka KV, Hunig T, Gold R, Kerkau T, Reichardt HM. Polyclonal expansion of regulatory t cells interferes with effector cell migration in a model of multiple sclerosis. Brain. 2006;129:2635-2647.
15. Gordon FL, Nguyen KB, White CA, Pender MP. Rapid entry and downregu-lation of t cells in the central nervous system during the reinduction of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2001;112:15-27.
16. Chen Y, Hancock WW, Marks R, Gonnella P, Weiner HL. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein t cell receptor transgenic mice. J Neuroimmunol. 1998;82:149-159.
17. Furtado GC, Olivares-Villagomez D, Curotto De Lafaille MA, Wensky AK, Latkowski JA, Lafaille JJ. Regulatory t cells in spontaneous autoimmune encephalomyelitis. Immunol Rev. 2001;182:122-134.
18. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia. 2001;36:118-124.
19. McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 2008;28:9451-9462.
20. Nguyen DN, Spapen H, Su F, Schiettecatte J, Shi L, Hachimi-Idrissi S, Huyghens L. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med. 2006;34:1967-1974.
21. Serres S, Anthony DC, Jiang Y, Broom KA, Campbell SJ, Tyler DJ, van Kasteren SI, Davis BG, Sibson NR. Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J Neurosci. 2009;29:4820-4828.
22. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Stroke. 2006;37:2508-2513.
23. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, Laskowitz DT, Valkirs GE, Buechler KF. Early biomarkers of stroke. Clin Chem. 2003;49:1733-1739.
24. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28:1956-1960.
25. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008;32:200-219.
26. Kaur C, Ling EA. Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res. 2008;5:71-81.
27. Schroeter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol. 1994;55:195-203.
28. Savva GM, Stephan BC. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke. 41:e41-e46.
29. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006-1018.